BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11961154)

  • 1. Successful gene therapy for severe combined immunodeficiency.
    Rosen FS
    N Engl J Med; 2002 Apr; 346(16):1241-3. PubMed ID: 11961154
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gene therapy of severe combined immunodeficiencies].
    Cavazzana-Calvo M; Hacein-Bey S; de Saint-Basile G; Le Deist F; Fischer A
    Transfus Clin Biol; 2000 Jun; 7(3):259-60. PubMed ID: 10919216
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy. The best of times, the worst of times.
    Anderson WF
    Science; 2000 Apr; 288(5466):627-9. PubMed ID: 10799000
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Le Deist F; De Saint Basile G; Cavazzana-Calvo M
    Adv Exp Med Biol; 2001; 495():199-204. PubMed ID: 11774567
    [No Abstract]   [Full Text] [Related]  

  • 5. Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID).
    Leonard WJ; Noguchi M; Russell SM
    Adv Exp Med Biol; 1994; 365():225-32. PubMed ID: 7887307
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy for XSCID: the first success of gene therapy.
    Kohn DB
    Pediatr Res; 2000 Nov; 48(5):578. PubMed ID: 11044472
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Bubble boy' paradox resolved.
    Nowak R
    Science; 1993 Dec; 262(5141):1818. PubMed ID: 8266068
    [No Abstract]   [Full Text] [Related]  

  • 8. The defective gene in X-linked severe combined immunodeficiency encodes a shared interleukin receptor subunit: implications for cytokine pleiotropy and redundancy.
    Leonard WJ
    Curr Opin Immunol; 1994 Aug; 6(4):631-5. PubMed ID: 7946053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene therapy for severe combined immunodeficiency linked to chromosome X].
    Fischer A
    Hematol Cell Ther; 1997 Apr; 39(2):97. PubMed ID: 9229544
    [No Abstract]   [Full Text] [Related]  

  • 10. X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years.
    Leonard WJ
    Mol Med Today; 2000 Oct; 6(10):403-7. PubMed ID: 11006530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling.
    Leonard WJ
    Annu Rev Med; 1996; 47():229-39. PubMed ID: 8712778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine lymphocyte expression of retrovirally transferred human common gamma chain.
    Whitwam T; Haskins ME; Henthorn PS; Bodine DM; Puck JM
    Ann N Y Acad Sci; 1999 Apr; 872():387-90. PubMed ID: 10372141
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacillus species infection of the skin as a presentation of severe combined immunodeficiency disease.
    Machado LS; Sleasman JW; Ford MJ
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):285-7. PubMed ID: 9704850
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.
    Candotti F; O'Shea JJ; Villa A
    Springer Semin Immunopathol; 1998; 19(4):401-15. PubMed ID: 9618765
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
    Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
    N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.
    Stephan V; Wahn V; Le Deist F; Dirksen U; Broker B; Müller-Fleckenstein I; Horneff G; Schroten H; Fischer A; de Saint Basile G
    N Engl J Med; 1996 Nov; 335(21):1563-7. PubMed ID: 8900089
    [No Abstract]   [Full Text] [Related]  

  • 17. Retroviral gene therapy--where now?
    Günzburg WH
    Trends Mol Med; 2003 Jul; 9(7):277-8. PubMed ID: 12900211
    [No Abstract]   [Full Text] [Related]  

  • 18. Recipient T-cell immune reconstitution in X-linked SCID after haploidentical maternal bone marrow transplant.
    de la Morena MT; Wayne AS; Day NK; Haag MM; Hinds-Frey KR; Nelson RP; Sutcliffe MJ; Good RA
    Ann N Y Acad Sci; 1995 Dec; 770():376-7. PubMed ID: 8597380
    [No Abstract]   [Full Text] [Related]  

  • 19. [Successful gene therapy of children with severe immunodeficiency. Research breakthrough hopefully for the treatment of other diseases, too].
    Fasth A; Mellgren K; Karlsson S; Richter J
    Lakartidningen; 2002 Jul; 99(28-29):3010-2. PubMed ID: 12170507
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Le Deist F; Soudais C; Di Santo JP; de Saint Basile G; Cavazzana-Calvo M
    Immunol Rev; 2000 Dec; 178():13-20. PubMed ID: 11213798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.